Holen Sie sich die Stockscreener-App
2.99
6.41%
0.18
Finanzdaten der Inozyme Pharma Inc-Aktie (INZY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
6.74%
24.34
|
22.81 | 18.07 | 16.39 | 18.37 |
| Interest Income/Expense |
1.325
|
- | - | - | - |
| Depreciation and Amortization |
3.41%
0.182
|
0.176 | 0.208 | 0.209 | 0.207 |
| Operating Income/Loss |
6.74%
-24.34
|
-22.81 | -18.07 | -16.39 | -18.37 |
| Nonoperating Income/Loss |
21.04%
0.998
|
1.264 | 1.436 | 0.811 | 0.965 |
| Income/Loss From Continuing Operations Before Tax |
8.37%
-23.35
|
-21.54 | -16.64 | -15.58 | -17.40 |
| Income/Loss From Continuing Operations After Tax |
8.37%
-23.35
|
-21.54 | -16.64 | -15.58 | -17.40 |
|
Net Income/Loss
|
8.37%
-23.35
|
-21.54 | -16.64 | -15.58 | -17.40 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,747%
61.77
|
3.345 | 56.76 | 44.86 | 43.72 |
| Diluted Average Shares |
1,747%
61.77
|
3.345 | 56.76 | 44.86 | 43.72 |
| Basic Earnings Per Share |
8.57%
-0.38
|
-0.35 | -0.29 | -0.35 | -0.40 |
| Diluted Earnings Per Share |
8.57%
-0.38
|
-0.35 | -0.29 | -0.35 | -0.40 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):